ACTRN12614000460606
已完成
未知
A randomised single blinded cross over trial to investigate the effect of Zespri green kiwifruit on digestive and gut health function in healthy participants and individuals with irritable bowel syndrome (constipation).
Zespri International0 个研究点目标入组 60 人2014年5月2日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Constipation
- 发起方
- Zespri International
- 入组人数
- 60
- 状态
- 已完成
- 最后更新
- 6年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Healthy group: Adult (18\-65 years); BMI 18\-35; Generally healthy; Normal bowel habits
- •Functionally constipated group: 1\.Adult (18\-65 years); Females will be required to declare stage of menstrual cycle during the different trial phases; BMI between 18\-35; Presence of functional constipation according to ROME III diagnostic criteria for functional constipation.
- •IBS\-C group: 1\.Adult (18\-65 years); Females will be required to declare stage of menstrual cycle during the different trial phases; BMI between 18\-35; Presence of functional constipation according to ROME III diagnostic criteria for IBSC.
排除标准
- •Individuals with alarm features associated with bowel habit (recent changes in bowel habit (\<3 months), rectal bleeding, weight loss, occult blood in stools, anaemia) , anal fissures, bleeding haemorrhoids, and family history of GI cancer or IBD.
- •Chronic disease (cardiovascular, cancer, renal failure, previous gastrointestinal surgery (not including appendectomy or cholecystectomy), neurological conditions (e.g. multiple sclerosis, spinal chord injury, stroke).
- •All patients will be screened at recruitment for fasting blood glucose. Those with results greater than 7\.2 mmol/l will not be accepted into the trial.
- •Participants with diagnosed and stable conditions requiring the use of SSRI’s (selective serotonin reuptake inhibitors), tricyclates, opiates or anti\-inflammatories will be permitted into the trial on condition the medication has been in use continually and the condition has been stable for \> 3 months. Similarly those with stable and controlled diabetes (\> 3 months) will be permitted to participate.
- •Women who are pregnant, breastfeeding or planning a pregnancy in the 3 months post selection (trial period) will be excluded.
- •Potential participants with known kiwifruit or latex allergy will be excluded.
- •Potential participants using laxatives who are not prepared to stop using the laxatives for the 2 week lead\-in period will be excluded.
结局指标
主要结局
未指定
相似试验
已完成
不适用
Cross-over randomised trial of adult hypothyroidism screeningPrimary hypothyroidismNutritional, Metabolic, EndocrineOther hypothyroidismISRCTN00049084Queen Mary University of London (UK)60
进行中（未招募）
不适用
Double blind randomised cross-over trial to assess the value of screening an adult population for hypothyroidism - CROSS OVER RANDOMISED TRIAL OF ADULT HYPOTHROIDISM SCREENINGEUCTR2005-003464-30-GBQueen Mary, University of London
已完成
不适用
Foot Orthoses (FOs) on Pain, Quality of Life and Gait with Children Diagnosed with Juvenile Idiopathic Arthritis (JIA).Juvenile Idiopathic Arthritis (JIA)Inflammatory and Immune System - Other inflammatory or immune system disordersACTRN12613001336774niversity of Newcastle (NSW)60
已完成
不适用
The Effect of SunGold Kiwifruit on Gut Health FunctioConstipationIrritable Bowel SyndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiet and Nutrition - Other diet and nutrition disordersACTRN12616000775415The New Zealand Institute for Plant & Food Research50
进行中（未招募）
1 期
A research study to compare two treatments for treating a respiratory disease known as asthma-COPD overlap syndrome (ACOS).EUCTR2015-002046-31-HUMundipharma Research Limited130